BlackRock Capital Allocation Term Trust of (BCAT) — RQD Stock Rating Cockpit

$13.81 +1.84% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

BlackRock Capital Allocation Term Trust of (BCAT) carries a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $1.49B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510053
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+
Cash (11)Whales (10)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-2.2% Base Target
$17 Bull$14 Base$11 Bear
📬 FREE BCAT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BCAT)Realized 20D OHLCV Swing Band: ±3.4%
RSI-14 MOMENTUMNEUTRAL RANGE
52.430 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE27% OF RANGE
L: $13$13.81H: $16
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: D+RQD 11 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 19 / 40
3. Hidden Risks & Market Weather● WATCH
SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 23 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on BCAT

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (55)

14.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (65)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (48)

19/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like BCAT
  • ✓Established market leader in Financials with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BCAT)

  • ✓Walkthrough of BCAT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BCAT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -8.54%📐 HORIZONTAL RANGE
2026-10-30O $13.70H $13.93L $13.65C $13.81VOL 709.0K
RES: $16.24SUP: $12.63SMA50: $14.34SMA200: $15.03
$16.43$15.48$14.52$13.57$12.61RES $16.24SUP $12.63$13.812026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BCAT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BCAT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BCAT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BCAT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCAT)

Financials Rank #735 of 1096 ⚔️ ECAT vs BCAT Full Matrix →

1. Head-to-Head Financials Peer Comparison (BCAT vs. ECAT, KYN, BTZ, BCX)

Industry: Finance/Investors Services (37 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, BlackRock Capital Allocation Term Trust of (BCAT) ranks #735 by composite RQD confidence (53/100, grade D+) and #490 by equity capitalization ($1.49B). Within this direct 5-issuer industry benchmark cohort, BCAT leads on earnings valuation at N/A trailing P/E, while BCAT leads on capital efficiency and profitability with — ROIC and — gross margin. KYN currently holds the highest overall quantitative score in the immediate peer group at 60/100 (C-) compared with BCAT at 53/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
BCAT ACTIVE
BlackRock Capital Allocation Term Trust of
D+ 53/100 — — — +1.84% $1.49B Benchmark Subject
ECAT
BlackRock ESG Capital Allocation Term Trust of
D 51/100 — — — +1.41% $1.47B /ecat-vs-bcat →
KYN
Kayne Anderson Energy Infrastructure Fund Inc.
C- 60/100 — — — +2.30% $2.00B /kyn-vs-bcat →
BTZ
BlackRock Credit Allocation Income Trust
D+ 54/100 — — — +1.16% $1.04B /btz-vs-bcat →
BCX
BlackRock Resources of
D+ 57/100 — — — +0.67% $1.02B /bcx-vs-bcat →

2. BCAT Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

BlackRock Capital Allocation Term Trust of (BCAT) operates in Finance/Investors Services (Financials) with an equity capitalization of $1.49B, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. BCAT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BCAT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, BlackRock Capital Allocation Term Trust of (NYSE: BCAT) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $13.81 (+1.84% 1D, market cap $1.49B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, BCAT ranks #735 in composite RQD confidence.

How does BCAT compare to ECAT and KYN in the Financials sector?

Within the Financials sector (Finance/Investors Services), BCAT carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, ECAT (BlackRock ESG Capital Allocation Term Trust of) holds a D grade (51/100 RQD, P/E N/A, ROIC —, cap $1.47B) and KYN (Kayne Anderson Energy Infrastructure Fund Inc.) posts a C- grade (60/100 RQD, P/E N/A, ROIC —, cap $2.00B). Among the 5-stock peer group, BCAT leads on earnings multiple (N/A) while BCAT leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for BCAT?

For BlackRock Capital Allocation Term Trust of (BCAT), key quantitative strengths include Established market leader in Financials with deep daily trading liquidity. and sector rank #735 in Financials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is BCAT trading relative to its 50-day, 200-day, and 52-week technical levels?

BCAT last traded at $13.81 (+1.84% on volume of 507,434 shares), positioning the stock -3.70% below its 50-day simple moving average ($14.34) and -8.12% below its 200-day simple moving average ($15.03). Across its 52-week range of $12.92 to $16.20, BCAT sits at the 27.1% percentile with a 14-day RSI of 52.4 (NEUTRAL RANGE) and an implied next-earnings move of ±3.4% ($13.34 to $14.28).

BCAT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell BCAT stock right now?

BlackRock Capital Allocation Term Trust of (BCAT) currently earns a Roarable Rating of D+ (Sell — SELL) with 53/100 RQD Confidence. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.

What is BCAT's 12-month price target and RQD AI Jury consensus?

BCAT's 12-month base price target is $13.5 (range $10.53 to $17.01), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%